Advertisement
Screener

SCHOLAR ROCK HOLDING CORPORATION (SRRK) Auditor

SCHOLAR ROCK HOLDING CORPORATION Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-03: Fiscal year end 2025-12-31; Auditor Deloitte & Touche LLP; PCAOB firm ID 34; Location Boston,.
  • 2025-02-27: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2024-03-19: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
  • 2023-03-07: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-032025-12-31Deloitte & Touche LLP34Boston,No
2025-02-272024-12-31Ernst & Young LLP42Boston, MassachusettsNo
2024-03-192023-12-31Ernst & Young LLP42Boston, MassachusettsNo
2023-03-072022-12-31Ernst & Young LLP42Boston, MassachusettsNo
2022-03-072021-12-31Ernst & Young LLP42Boston, MassachusettsNo
2021-03-092020-12-31Ernst & Young LLPBoston, MassachusettsNo
2020-03-122019-12-31Ernst & Young LLPBoston, Massachusetts
2019-03-192018-12-31Ernst & Young LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
CG Oncology, Inc. (CGON)United States$6.095B-27.95
CRISPR Therapeutics AG (CRSP)$5.390B-11.68
IOVANCE BIOTHERAPEUTICS, INC. (IOVA)United States$4.897B-6.51
Immunovant, Inc. (IMVT)United States$7.028B-14.78
Adaptive Biotechnologies Corp (ADPT)United States$4.719B-53.43
Relay Therapeutics, Inc. (RLAY)United States$3.884B-14.30
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Tarsus Pharmaceuticals, Inc. (TARS)United States$3.329B-58.60
Denali Therapeutics Inc. (DNLI)United States$3.274B-8.04
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29